Literature DB >> 3310046

Serum enzymes of drug metabolism.

F M Williams1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3310046     DOI： 10.1016/0163-7258(87)90094-5

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  10 in total

Review 1.  Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

Authors:  A Nordberg; A L Svensson
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

2.  Benorylate hydrolysis by human plasma and human liver.

Authors:  F M Williams; U Moore; R A Seymour; E M Mutch; E Nicholson; P Wright; H Wynne; P G Blain; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 3.  Overview of extracellular microvesicles in drug metabolism.

Authors:  Javier Conde-Vancells; Esperanza Gonzalez; Shelly C Lu; Jose M Mato; Juan M Falcon-Perez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-05       Impact factor: 4.481

4.  Isolation, identification and biological activity of a phyllanthoside metabolite produced in vitro by mouse plasma.

Authors:  D E Chapman; D J Moore; D C Melder; A Breau; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Pharmacokinetics of physostigmine in man following a single application of a transdermal system.

Authors:  K Walter; M Müller; M F Barkworth; A V Nieciecki; F Stanislaus
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 6.  Medication prescribing in frail older people.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Kenneth W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2012-09-11       Impact factor: 2.953

7.  Plasma esterases and inflammation in ageing and frailty.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Brian L Calver; Ken W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 2.953

8.  Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state.

Authors:  Alessandro Villa; Barbara Klein; Bieneke Janssen; Jordi Pedragosa; Giovanna Pepe; Bastian Zinnhardt; Danielle J Vugts; Paolo Gelosa; Luigi Sironi; Wissam Beaino; Annelaure Damont; Frédéric Dollé; Benoit Jego; Alexandra Winkeler; Dieter Ory; Olof Solin; Johnny Vercouillie; Uta Funke; Sandra Laner-Plamberger; Linda V Blomster; Palle Christophersen; Elisabetta Vegeto; Ludwig Aigner; Andreas Jacobs; Anna M Planas; Adriana Maggi; Albert D Windhorst
Journal:  Theranostics       Date:  2018-10-27       Impact factor: 11.556

9.  Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical.

Authors:  Arijit Ghosh; Karen Woolum; Shankaran Kothandaraman; Michael F Tweedle; Krishan Kumar
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

10.  A single low-energy shockwave pulse opens blood-cerebrospinal fluid barriers and facilitates gastrodin delivery to alleviate epilepsy.

Authors:  Yi Kung; Ming-Yen Hsiao; Shu-Mei Yang; Tz-Yi Wen; Moxian Chen; Wei-Hao Liao; Chueh-Hung Wu; Lijuan Ao; Wen-Shiang Chen
Journal:  Ultrason Sonochem       Date:  2021-08-25       Impact factor: 7.491
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.